Article Per Year (5 Year)
p-Index From 2021 - 2026
0.408
P-Index
This Author published in this journals
All Journal Acta Pharmaciae Indonesia : Acta Pharm Indo PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia)
Ilmi, Yuniar Fathil
Unknown Affiliation
Materials Science & Nanotechnology Medicine & Pharmacology

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Analytical agreement between CEDIA immunoassay and HPLC for therapeutic drug monitoring of carbamazepine: a narrative review Mulki, Munir Alinu; Fitriana, Nariyyah; Ilmi, Yuniar Fathil; Utami, Marsah Rahmawati
Acta Pharmaciae Indonesia Vol 13 No 1 (2025): Acta Pharmaciae Indonesia: Acta Pharm Indo
Publisher : Pharmacy Department, Faculty of Health Sciences, Jenderal Soedirman University, Purwokerto, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20884/1.api.2025.13.1.16526

Abstract

speed, simplicity, and cost, but the extent of its agreement with HPLC across diverse clinical contexts requires careful evaluation. Method: This narrative review synthesizes evidence from nine studies identified through Scopus and Google Scholar to assess the analytical agreement and clinical validity of CEDIA and related immunoassay platforms compared to HPLC and advanced chromatographic methods. Results: The reviewed evidence demonstrates strong inter-method correlation, although systematic positive bias in immunoassay results is consistently observed, particularly in patients receiving enzyme-inducing co-medications where carbamazepine-10,11-epoxide accumulation affects antibody cross-reactivity. CEDIA is analytically acceptable for routine CBZ TDM in stable patients on monotherapy. HPLC and LC-MS/MS remain preferable when metabolite quantification, polytherapy monitoring, or precise measurement near therapeutic boundaries is clinically required. Conclusion: Method selection should be guided by the clinical question, patient population characteristics, and available laboratory resources.
Pengaruh Asupan Vitamin K terhadap Stabilitas Rasio Normalisasi Internasional dan Efektivitas Terapi Warfarin Ilmi, Yuniar Fathil; Fitriana, Nariyyah; Mulki, Munir Alinu; Hilmi, Indah Laily
PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) Jurnal Pharmacy, Vol. 22 No. 02 Desember 2025
Publisher : Pharmacy Faculty, Universitas Muhammadiyah Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30595/pharmacy.v22i2.26889

Abstract

Warfarin memiliki indeks terapi sempit dengan variabilitas respons tinggi. Fluktuasi asupan vitamin K dapat menyebabkan ketidakstabilan INR, namun hubungannya masih kontroversial. Tinjauan ini bertujuan untuk mengevaluasi pengaruh asupan vitamin K terhadap stabilitas INR dan efektivitas terapi warfarin. Tinjauan sistematis mengikuti PRISMA 2020 melalui PubMed (2010-2025). Dari 6.573 artikel, 9 studi di sertakan (4 RCT, 5 observasional) dengan penilaian kualitas menggunakan Cochrane RoB 2 dan Newcastle-Ottawa Scale. Hasil menunjukkan konsistensi asupan vitamin K lebih penting dibanding jumlah absolut dalam menjaga stabilitas INR. Suplementasi dosis rendah (150 mcg/hari) efektif menurunkan fluktuasi ekstrem INR. Pemberian vitamin K untuk INR tinggi (≥4) aman dan efektif menurunkan risiko perdarahan serta mortalitas tanpa meningkatkan tromboembolisme. Dapat disimpulkan bahwa konsistensi konsumsi vitamin K merupakan faktor kunci efektivitas terapi warfarin. Edukasi harus menekankan konsistensi daripada pembatasan ketat. Diperlukan RCT berskala besar dengan tindak lanjut lebih panjang dan integrasi data genetik.
Co-Authors Fitriana, Nariyyah Indah Laily Hilmi Marsah Rahmawati Utami Munir Alinu Mulki